ZBH
Zimmer Biomet Holdings, Inc.
Price Chart
Latest Quote
$86.22
Current Price| Previous Close | $87.07 |
| Open | $86.69 |
| Day High | $87.85 |
| Day Low | $86.02 |
| Volume | 1,836,381 |
Stock Information
| Quarterly Dividend / Yield | $0.96 / 1.11% |
| Shares Outstanding | 198.18M |
| Total Debt | $8.24B |
| Cash Equivalents | $1.31B |
| Revenue | $8.01B |
| Net Income | $805.30M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $17.09B |
| P/E Ratio | 21.39 |
| EPS (TTM) | $4.03 |
| Exchange | NYQ |
📊 Custom Metrics & Score
Score: 10/42| Debt to Equity | 0.50 |
| Debt to Earnings | 1.13 |
| Current Ratio | 1.91 |
| Quick Ratio | 0.82 |
| Avg Revenue Growth | 3.12% |
| Profit Margin | 11.77% |
| Return on Equity | 7.25% |
| Avg FCF Growth | -3.80% |
| FCF Yield | 6.69% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $86.22 | 1,836,381 |
| 2026-01-30 | $87.07 | 1,826,000 |
| 2026-01-29 | $86.02 | 2,137,400 |
| 2026-01-28 | $85.71 | 1,746,900 |
| 2026-01-27 | $85.99 | 2,188,900 |
| 2026-01-26 | $87.32 | 1,555,200 |
| 2026-01-23 | $86.60 | 1,797,400 |
| 2026-01-22 | $87.54 | 2,160,200 |
| 2026-01-21 | $86.55 | 2,688,500 |
| 2026-01-20 | $86.80 | 1,948,500 |
| 2026-01-16 | $87.31 | 2,681,300 |
| 2026-01-15 | $88.75 | 3,090,800 |
| 2026-01-14 | $89.24 | 3,977,300 |
| 2026-01-13 | $88.34 | 4,140,300 |
| 2026-01-12 | $91.45 | 1,645,000 |
| 2026-01-09 | $92.85 | 2,362,100 |
| 2026-01-08 | $94.08 | 1,636,400 |
| 2026-01-07 | $92.67 | 2,278,300 |
| 2026-01-06 | $94.75 | 1,908,200 |
| 2026-01-05 | $92.65 | 1,990,400 |
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also develops surgical robot to enable placement of patient optimized orthopedic implants in the United States. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
📰 Latest News
Piper Sandler Maintains Overweight Rating on Stryker Corporation (SYK)
Insider Monkey • 2026-01-30T19:31:39Z
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Affirm Holdings, Alcoa, Block, Coinbase Global,CoreWeave, Datadog, Intuitive Surgical, and More
24/7 Wall St. • 2026-01-27T13:00:46Z
What Analysts Think Is Reframing Zimmer Biomet (ZBH) Story For Investors
Simply Wall St. • 2026-01-27T12:09:30Z
3 Value Stocks with Open Questions
StockStory • 2026-01-26T04:32:41Z
Zimmer Biomet Holdings (ZBH)’s 2026 Expectations Remain Cautious Amid Internal Reset
Insider Monkey • 2026-01-21T12:11:07Z
Q3 Rundown: Zimmer Biomet (NYSE:ZBH) Vs Other Surgical Equipment & Consumables - Diversified Stocks
StockStory • 2026-01-21T03:35:41Z
3 Cash-Producing Stocks with Open Questions
StockStory • 2026-01-19T04:39:43Z
Is It Time To Reassess Zimmer Biomet (ZBH) After Prolonged Share Price Weakness
Simply Wall St. • 2026-01-18T22:07:20Z
1 Profitable Stock to Research Further and 2 Facing Challenges
StockStory • 2026-01-16T04:40:17Z
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
Zacks • 2026-01-15T14:40:05Z
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Reconciled Cost Of Revenue | $1,786,800,000 | $1,693,600,000 | $1,619,900,000 | $1,552,200,000 |
| Cost Of Revenue | $2,191,200,000 | $2,083,800,000 | $2,019,500,000 | $1,960,400,000 |
| Total Revenue | $7,678,600,000 | $7,394,200,000 | $6,939,900,000 | $6,827,300,000 |
| Operating Revenue | $7,678,600,000 | $7,394,200,000 | $6,939,900,000 | $6,827,300,000 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Expense | $218,000,000 | $201,200,000 | $164,800,000 | $208,400,000 |
| Total Expenses | $6,150,300,000 | $5,942,900,000 | $5,747,800,000 | $5,821,900,000 |
| Other Income Expense | $-273,700,000 | $-182,900,000 | $-623,800,000 | $-298,000,000 |
| Other Non Operating Income Expenses | $-31,100,000 | $-9,300,000 | $-128,000,000 | $12,200,000 |
| Net Non Operating Interest Income Expense | $-218,000,000 | $-201,200,000 | $-164,800,000 | $-208,400,000 |
| Interest Expense Non Operating | $218,000,000 | $201,200,000 | $164,800,000 | $208,400,000 |
| Operating Expense | $3,959,100,000 | $3,859,100,000 | $3,728,300,000 | $3,861,500,000 |
| Other Operating Expenses | - | - | $33,800,000 | $52,800,000 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $903,800,000 | $1,024,000,000 | $290,200,000 | $445,000,000 |
| Net Interest Income | $-218,000,000 | $-201,200,000 | $-164,800,000 | $-208,400,000 |
| Normalized Income | $1,115,589,800 | $1,190,656,000 | $647,671,800 | $722,008,600 |
| Net Income From Continuing And Discontinued Operation | $903,800,000 | $1,024,000,000 | $231,400,000 | $401,600,000 |
| Total Operating Income As Reported | $1,285,700,000 | $1,277,700,000 | $696,300,000 | $860,300,000 |
| Net Income Common Stockholders | $903,800,000 | $1,024,000,000 | $231,400,000 | $401,600,000 |
| Net Income | $903,800,000 | $1,024,000,000 | $231,400,000 | $401,600,000 |
| Net Income Including Noncontrolling Interests | $905,200,000 | $1,025,100,000 | $232,400,000 | $402,100,000 |
| Net Income Discontinuous Operations | $0 | $0 | $-58,800,000 | $-43,400,000 |
| Net Income Continuous Operations | $905,200,000 | $1,025,100,000 | $291,200,000 | $445,500,000 |
| Pretax Income | $1,036,600,000 | $1,067,300,000 | $403,500,000 | $499,000,000 |
| Special Income Charges | $-242,600,000 | $-173,600,000 | $-495,800,000 | $-310,200,000 |
| Operating Income | $1,528,300,000 | $1,451,300,000 | $1,192,100,000 | $1,005,400,000 |
| Depreciation Amortization Depletion Income Statement | $591,900,000 | $561,500,000 | $526,800,000 | $529,500,000 |
| Depreciation And Amortization In Income Statement | $591,900,000 | $561,500,000 | $526,800,000 | $529,500,000 |
| Amortization Of Intangibles Income Statement | $591,900,000 | $561,500,000 | $526,800,000 | $529,500,000 |
| Gross Profit | $5,487,400,000 | $5,310,400,000 | $4,920,400,000 | $4,866,900,000 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $4.43 | $4.88 | $1.10 | $1.91 |
| Basic EPS | $4.45 | $4.91 | $1.10 | $1.93 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $-30,810,200 | $-6,944,000 | $-138,328,200 | $-33,191,400 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $2,493,500,000 | $2,393,800,000 | $1,990,500,000 | $1,955,300,000 |
| Total Unusual Items | $-242,600,000 | $-173,600,000 | $-495,800,000 | $-310,200,000 |
| Total Unusual Items Excluding Goodwill | $-242,600,000 | $-173,600,000 | $-495,800,000 | $-310,200,000 |
| Reconciled Depreciation | $996,300,000 | $951,700,000 | $926,400,000 | $937,700,000 |
| EBITDA (Bullshit earnings) | $2,250,900,000 | $2,220,200,000 | $1,494,700,000 | $1,645,100,000 |
| EBIT | $1,254,600,000 | $1,268,500,000 | $568,300,000 | $707,400,000 |
| Diluted Average Shares | $203,900,000 | $209,700,000 | $210,300,000 | $210,400,000 |
| Basic Average Shares | $203,100,000 | $208,700,000 | $209,600,000 | $208,600,000 |
| Diluted NI Availto Com Stockholders | $903,800,000 | $1,024,000,000 | $231,400,000 | $401,600,000 |
| Minority Interests | $-1,500,000 | $-1,100,000 | $-1,000,000 | $-500,000 |
| Tax Provision | $131,400,000 | $42,200,000 | $112,300,000 | $53,500,000 |
| Impairment Of Capital Assets | $0 | $0 | $292,800,000 | $16,300,000 |
| Restructuring And Mergern Acquisition | $242,600,000 | $173,600,000 | $203,000,000 | $128,800,000 |
| Amortization | $591,900,000 | $561,500,000 | $526,800,000 | $529,500,000 |
| Research And Development | $437,400,000 | $458,700,000 | $406,000,000 | $435,800,000 |
| Selling General And Administration | $2,929,800,000 | $2,838,900,000 | $2,761,700,000 | $2,843,400,000 |
| Other Special Charges | - | - | - | $165,100,000 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $-1,081,400,000 | $-1,194,400,000 | $-1,623,700,000 | $-1,792,300,000 |
| Total Assets | $21,365,300,000 | $21,496,900,000 | $21,066,000,000 | $23,456,400,000 |
| Total Non Current Assets | $16,693,800,000 | $16,887,400,000 | $16,638,700,000 | $18,571,400,000 |
| Other Non Current Assets | $1,095,500,000 | $1,152,100,000 | $1,122,200,000 | $2,281,800,000 |
| Goodwill And Other Intangible Assets | $13,549,500,000 | $13,674,900,000 | $13,644,000,000 | $14,453,000,000 |
| Other Intangible Assets | $4,598,400,000 | $4,856,400,000 | $5,063,800,000 | $5,533,600,000 |
| Current Assets | $4,671,500,000 | $4,609,500,000 | $4,427,300,000 | $4,885,000,000 |
| Other Current Assets | $430,000,000 | $366,100,000 | $522,900,000 | $271,000,000 |
| Inventory | $2,235,300,000 | $2,385,200,000 | $2,147,200,000 | $2,148,000,000 |
| Receivables | $1,480,700,000 | $1,442,400,000 | $1,381,500,000 | $1,259,600,000 |
| Accounts Receivable | $1,480,700,000 | $1,442,400,000 | $1,381,500,000 | $1,259,600,000 |
| Allowance For Doubtful Accounts Receivable | $-93,200,000 | $-75,100,000 | $-78,400,000 | $-60,100,000 |
| Gross Accounts Receivable | $1,573,900,000 | $1,517,500,000 | $1,459,900,000 | $1,319,700,000 |
| Cash Cash Equivalents And Short Term Investments | $525,500,000 | $415,800,000 | $375,700,000 | $378,100,000 |
| Cash And Cash Equivalents | $525,500,000 | $415,800,000 | $375,700,000 | $378,100,000 |
| Assets Held For Sale Current | - | - | $0 | $501,600,000 |
| Prepaid Assets | - | - | $198,400,000 | $326,700,000 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Debt | $5,679,100,000 | $5,352,100,000 | $5,320,800,000 | $6,690,700,000 |
| Total Debt | $6,204,600,000 | $5,767,900,000 | $5,696,500,000 | $7,068,800,000 |
| Long Term Debt And Capital Lease Obligation | $5,341,600,000 | $4,867,900,000 | $5,152,200,000 | $5,463,700,000 |
| Long Term Debt | $5,341,600,000 | $4,867,900,000 | $5,152,200,000 | $5,463,700,000 |
| Current Debt And Capital Lease Obligation | $863,000,000 | $900,000,000 | $544,300,000 | $1,605,100,000 |
| Current Debt | $863,000,000 | $900,000,000 | $544,300,000 | $1,605,100,000 |
| Other Current Borrowings | $863,000,000 | $900,000,000 | $544,300,000 | $1,605,100,000 |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $8,889,100,000 | $9,008,800,000 | $9,039,000,000 | $10,790,000,000 |
| Total Non Current Liabilities Net Minority Interest | $6,438,200,000 | $6,151,400,000 | $6,680,800,000 | $7,322,100,000 |
| Other Non Current Liabilities | $744,100,000 | $925,900,000 | $632,600,000 | $548,500,000 |
| Non Current Deferred Liabilities | $352,500,000 | $357,600,000 | $474,800,000 | $558,500,000 |
| Non Current Deferred Taxes Liabilities | $352,500,000 | $357,600,000 | $474,800,000 | $558,500,000 |
| Current Liabilities | $2,450,900,000 | $2,857,400,000 | $2,358,200,000 | $3,467,900,000 |
| Other Current Liabilities | $286,000,000 | $326,100,000 | $502,800,000 | $640,500,000 |
| Payables And Accrued Expenses | $1,301,900,000 | $1,631,300,000 | $1,311,100,000 | $1,222,300,000 |
| Payables | $194,600,000 | $410,600,000 | $392,600,000 | $368,500,000 |
| Accounts Payable | $194,600,000 | $410,600,000 | $354,100,000 | $306,500,000 |
| Derivative Product Liabilities | - | $-144,700,000 | $-172,000,000 | $-10,500,000 |
| Tradeand Other Payables Non Current | - | $273,700,000 | $421,200,000 | $583,000,000 |
| Total Tax Payable | - | $61,200,000 | $38,500,000 | $62,000,000 |
| Income Tax Payable | - | $61,200,000 | $38,500,000 | $62,000,000 |
| Liabilities Heldfor Sale Non Current | - | - | $0 | $168,400,000 |
| Current Deferred Liabilities | - | - | - | $0 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $12,468,100,000 | $12,480,500,000 | $12,020,300,000 | $12,660,700,000 |
| Total Equity Gross Minority Interest | $12,476,200,000 | $12,488,100,000 | $12,027,000,000 | $12,666,400,000 |
| Stockholders Equity | $12,468,100,000 | $12,480,500,000 | $12,020,300,000 | $12,660,700,000 |
| Gains Losses Not Affecting Retained Earnings | $-262,800,000 | $-191,000,000 | $-179,300,000 | $-231,600,000 |
| Other Equity Adjustments | $-262,800,000 | $-191,000,000 | $-179,300,000 | $-231,600,000 |
| Retained Earnings | $11,095,300,000 | $10,384,500,000 | $9,559,300,000 | $10,292,200,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Treasury Shares Number | $118,400,000 | $110,600,000 | $104,800,000 | $103,800,000 |
| Ordinary Shares Number | $199,073,712 | $205,600,000 | $209,000,000 | $209,000,000 |
| Share Issued | $317,473,712 | $316,200,000 | $313,800,000 | $312,800,000 |
| Tangible Book Value | $-1,081,400,000 | $-1,194,400,000 | $-1,623,700,000 | $-1,792,300,000 |
| Invested Capital | $18,672,700,000 | $18,248,400,000 | $17,716,800,000 | $19,729,500,000 |
| Working Capital | $2,220,600,000 | $1,752,100,000 | $2,069,100,000 | $1,417,100,000 |
| Total Capitalization | $17,809,700,000 | $17,348,400,000 | $17,172,500,000 | $18,124,400,000 |
| Minority Interest | $8,100,000 | $7,700,000 | $6,700,000 | $5,700,000 |
| Treasury Stock | $8,405,700,000 | $7,562,300,000 | $6,867,200,000 | $6,717,800,000 |
| Additional Paid In Capital | $10,038,100,000 | $9,846,100,000 | $9,504,400,000 | $9,314,800,000 |
| Capital Stock | $3,200,000 | $3,200,000 | $3,100,000 | $3,100,000 |
| Common Stock | $3,200,000 | $3,200,000 | $3,100,000 | $3,100,000 |
| Current Accrued Expenses | $1,107,300,000 | $1,220,700,000 | $918,500,000 | $853,800,000 |
| Goodwill | $8,951,100,000 | $8,818,500,000 | $8,580,200,000 | $8,919,400,000 |
| Net PPE | $2,048,800,000 | $2,060,400,000 | $1,872,500,000 | $1,836,600,000 |
| Accumulated Depreciation | $-4,641,400,000 | $-4,705,800,000 | $-4,585,900,000 | $-4,301,100,000 |
| Gross PPE | $6,690,200,000 | $6,766,200,000 | $6,458,400,000 | $6,137,700,000 |
| Construction In Progress | $233,900,000 | $200,600,000 | $144,100,000 | $116,300,000 |
| Other Properties | $3,589,600,000 | $3,748,600,000 | $3,683,500,000 | $3,460,400,000 |
| Machinery Furniture Equipment | $575,100,000 | $552,200,000 | $518,200,000 | $454,900,000 |
| Buildings And Improvements | $2,273,100,000 | $2,245,900,000 | $2,093,400,000 | $2,086,000,000 |
| Land And Improvements | $18,500,000 | $18,900,000 | $19,200,000 | $20,100,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $1,771,700,000 | $1,831,200,000 | $1,655,000,000 | $1,729,200,000 |
| Work In Process | $175,100,000 | $246,500,000 | $230,900,000 | $175,500,000 |
| Raw Materials | $288,500,000 | $307,500,000 | $261,300,000 | $243,300,000 |
| Pensionand Other Post Retirement Benefit Plans Current | - | $417,100,000 | $336,200,000 | $317,600,000 |
| Current Deferred Revenue | - | - | - | $0 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $1,142,600,000 | $1,187,100,000 | $1,067,100,000 | $1,347,200,000 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $1,499,400,000 | $1,581,600,000 | $1,284,700,000 | $1,499,200,000 |
| Cash From Discontinued Operating Activities | $0 | $0 | $-71,500,000 | $94,900,000 |
| Cash Flow From Continuing Operating Activities | $1,499,400,000 | $1,581,600,000 | $1,356,200,000 | $1,404,300,000 |
| Operating Gains Losses | - | $-2,500,000 | $116,600,000 | $165,100,000 |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Capital Expenditure | $-356,800,000 | $-394,500,000 | $-217,600,000 | $-152,000,000 |
| Investing Cash Flow | $-888,100,000 | $-778,900,000 | $-529,200,000 | $-503,600,000 |
| Cash From Discontinued Investing Activities | $0 | $0 | $-7,200,000 | $-60,300,000 |
| Cash Flow From Continuing Investing Activities | $-888,100,000 | $-778,900,000 | $-522,000,000 | $-443,300,000 |
| Net Other Investing Changes | $-36,800,000 | $28,800,000 | $-35,700,000 | $-19,600,000 |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repurchase Of Capital Stock | $-868,000,000 | $-692,200,000 | $-126,400,000 | $0 |
| Financing Cash Flow | $-484,500,000 | $-763,500,000 | $-843,800,000 | $-1,306,000,000 |
| Cash From Discontinued Financing Activities | $0 | $0 | $-68,100,000 | $0 |
| Cash Flow From Continuing Financing Activities | $-484,500,000 | $-763,500,000 | $-775,700,000 | $-1,306,000,000 |
| Net Other Financing Charges | $-38,900,000 | $-26,100,000 | $534,500,000 | $-173,400,000 |
| Cash Dividends Paid | $-196,000,000 | $-200,900,000 | $-201,200,000 | $-200,100,000 |
| Common Stock Dividend Paid | $-196,000,000 | $-200,900,000 | $-201,200,000 | $-200,100,000 |
| Net Common Stock Issuance | $-868,000,000 | $-692,200,000 | $-126,400,000 | $0 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repayment Of Debt | $-850,000,000 | $-120,200,000 | $-1,518,700,000 | $-2,654,800,000 |
| Issuance Of Debt | $1,436,300,000 | $499,800,000 | $83,000,000 | $1,599,800,000 |
| End Cash Position | $525,500,000 | $415,800,000 | $375,700,000 | $478,500,000 |
| Beginning Cash Position | $415,800,000 | $375,700,000 | $478,500,000 | $802,100,000 |
| Effect Of Exchange Rate Changes | $-17,100,000 | $900,000 | $-14,500,000 | $-13,200,000 |
| Changes In Cash | $126,800,000 | $39,200,000 | $-88,300,000 | $-310,400,000 |
| Proceeds From Stock Option Exercised | $82,100,000 | $101,100,000 | $78,100,000 | $122,500,000 |
| Common Stock Payments | $-868,000,000 | $-692,200,000 | $-126,400,000 | $0 |
| Net Issuance Payments Of Debt | $536,300,000 | $54,600,000 | $-1,060,700,000 | $-1,055,000,000 |
| Net Short Term Debt Issuance | $-50,000,000 | $-325,000,000 | $375,000,000 | $0 |
| Net Long Term Debt Issuance | $586,300,000 | $379,600,000 | $-1,435,700,000 | $-1,055,000,000 |
| Long Term Debt Payments | $-850,000,000 | $-120,200,000 | $-1,518,700,000 | $-2,654,800,000 |
| Long Term Debt Issuance | $1,436,300,000 | $499,800,000 | $83,000,000 | $1,599,800,000 |
| Net Investment Purchase And Sale | $-218,200,000 | $-278,300,000 | $-168,900,000 | $-271,700,000 |
| Sale Of Investment | $22,100,000 | $33,400,000 | $89,400,000 | $1,900,000 |
| Purchase Of Investment | $-240,300,000 | $-311,700,000 | $-258,300,000 | $-273,600,000 |
| Net Business Purchase And Sale | $-276,300,000 | $-134,900,000 | $-99,800,000 | $0 |
| Purchase Of Business | $-276,300,000 | $-134,900,000 | $-99,800,000 | $0 |
| Net Intangibles Purchase And Sale | $-153,000,000 | $-103,400,000 | $-29,700,000 | $-8,400,000 |
| Purchase Of Intangibles | $-153,000,000 | $-103,400,000 | $-29,700,000 | $-8,400,000 |
| Net PPE Purchase And Sale | $-203,800,000 | $-291,100,000 | $-187,900,000 | $-143,600,000 |
| Purchase Of PPE | $-203,800,000 | $-291,100,000 | $-187,900,000 | $-143,600,000 |
| Change In Working Capital | $-455,400,000 | $-396,200,000 | $-311,400,000 | $-134,200,000 |
| Change In Other Working Capital | $-93,600,000 | $-48,600,000 | $-154,100,000 | $-171,500,000 |
| Change In Payables And Accrued Expense | $-322,000,000 | $-55,300,000 | $103,000,000 | $86,500,000 |
| Change In Inventory | $49,900,000 | $-240,400,000 | $-75,600,000 | $-8,400,000 |
| Change In Receivables | $-89,700,000 | $-51,900,000 | $-184,700,000 | $-40,800,000 |
| Stock Based Compensation | $101,000,000 | $99,800,000 | $105,000,000 | $76,000,000 |
| Asset Impairment Charge | $0 | $0 | $292,800,000 | $16,300,000 |
| Deferred Tax | $-47,700,000 | $-96,300,000 | $-64,400,000 | $-102,100,000 |
| Deferred Income Tax | $-47,700,000 | $-96,300,000 | $-64,400,000 | $-102,100,000 |
| Depreciation Amortization Depletion | $996,300,000 | $951,700,000 | $926,400,000 | $937,700,000 |
| Depreciation And Amortization | $996,300,000 | $951,700,000 | $926,400,000 | $937,700,000 |
| Gain Loss On Sale Of Business | $0 | $-2,500,000 | $116,600,000 | $0 |
| Net Income From Continuing Operations | $905,200,000 | $1,025,100,000 | $291,200,000 | $445,500,000 |
| Gain Loss On Investment Securities | - | - | $116,600,000 | - |